The Welch Group promotes the Medical Orders for Life-Sustaining Treatment (MOLST) program, a medical form designed to improve the quality of care patients receive at the end of life by translating their decisions about life-sustaining medical treatments into medical orders.
(PRWeb April 13, 2015)
Read the full story at http://www.prweb.com/releases/2015/04/prweb12643571.htm
For more information, please visit
http://www.prweb.com/releases/2015/04/prweb12643571.htm